To learn more, check out the short video, consider subscribing, and click the special offer link below. *Stock prices used were the after-market prices of Oct. 22, 2024. The video was published on Oct.
Griffin disposed of the lion's share of his fund's stake in artificial intelligence (AI) colossus Nvidia in favor of an AI company with seemingly insurmountable competitive advantages.
Nvidia CEO Jensen Huang admitted Wednesday that Nvidia was 100% at fault for a design flaw in the company's new Blackwell AI chips. The flaw has been fixed and the chips are now in production.
Nvidia is embarking on a series of partnerships with Indian firms to deploy its AI chips and technology, deepening its push into a key growth market.
Chip behemoth Nvidia expanded tie-ups on Thursday with India's big firms, such as Reliance Industries, and launched a lightweight artificial intelligence (AI) model for the widely-used Hindi language,
Artificial Intelligence is “fundamentally reshaping computing and will transform how stories are told, produced and experienced,” asserted NVIDIA founder and CEO Jensen Huang as he accepted the Charles F. Jenkins Lifetime Achievement Award via a recorded message during the 76th Engineering, Science & Technology Emmy Awards.
Nvidia is betting big on India, especially after its collaboration with companies like Reliance Industries, Infosys, and Tech Mahindra.
Pharmaceutical giant Novo Nordisk plans to use Denmark's first sovereign artificial intelligence supercomputer—powered by Nvidia technology—for drug discovery.
CEO Jensen Huang and Reliance Industries chairman Mukesh Ambani in conversation at the first-ever NVIDIA AI Summit in Mumbai, India.
MUMBAI: Nvidia will supply artificial intelligence processors to Indian companies such as Mukesh Ambani's Reliance, the chip giant said on Thursday (Oct 24), as it deepens partnerships to exploit a growing market.
Wipro's strategy leverages NVIDIA AI with ready-to-use templates based on NVIDIA NIM Agent Blueprints for faster business value in intelligent document processing, drug discovery, customer service, and claims processing.